Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia

www.lmu.de | UB | Browse | Help

Advanced Search

Deutsch

Advanced Search

Bornhäuser, Martin, Schliemann, Christoph, Schetelig, Johannes, Röllig, Christoph, Kramer, Michael, Glass, Bertram, Platzbecker, Uwe, Burchert, Andreas, Hänel, Mathias, Müller, Lutz P., Klein, Stefan, Bug, Gesine, Beelen, Dietrich, Rösler, Wolf, Schäfer-Eckart, Kerstin, Schmid, Christoph, Jost, Edgar, Lenz, Georg, Tischer, Johanna, Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957, Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690, Serve, Hubert, Stölzel, Friedrich, Alakel, Nael, Middeke, Jan Moritz, Thiede, Christian, Ehninger, Gerhard, Berdel, Wolfgang E. and Stelljes, Matthias (2023): Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia. In: JAMA Oncology, Vol. 9, No. 4: pp. 519-526

Full text not available from 'Open Access LMU'.

DOI: 10.1001/jamaoncol.2022.7605

Item Type:	Journal article
Faculties:	Medicine > Institute for Medical Information Processing, Biometry and Epidemiology
Subjects:	600 Technology > 610 Medicine and health
ISSN:	2374-2437
Language:	English
Item ID:	94641
Date Deposited:	15. Feb 2023 09:57
Last Modified:	23. Jun 2023 07:44

Actions (login required)

View Item